CardioMech secures $13 million for clinical trial of heart valve device

CardioMech is developing a heart valve repair device that treats degenerative mitral regurgitation, a cardiovascular ailment usually treated by open-heart surgery. It plans to open a clinical trial early next year.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news